9 - ATTD 2025 Highlights and New CGMs (Good, Bad and Ugly!)

In this episode of the Glucose Never Lies podcast, John Pemberton shares insights from the ATTD 2025 conference, discussing advancements in diabetes management technologies, including automated insulin delivery systems and continuous glucose monitoring. He emphasizes the importance of early intervention with AID systems, the role of GLP-1 receptor agonists, and the impact of exercise and nutrition on diabetes control. The conversation also highlights the need for equitable access to diabetes technology and the improvements in quality of life that these innovations can bring.

Takeaways

• Automated insulin delivery systems can improve glycemic control and quality of life.
• Starting AID systems early can lead to better long-term outcomes.
• GLP-1 receptor agonists show promise for type 2 diabetes management.
• Exercise plays a significant role in managing diabetes effectively.
• Nutrition strategies are essential for optimizing insulin delivery systems.
• Equity in access to diabetes technology is a pressing issue.
• Continuous glucose monitoring devices are rapidly evolving.
• The future of diabetes management looks promising with new technologies.

Chapters

00:00
Introduction to the Podcast and Personal Journey

02:14
Insights from ATTD 2025 Conference

03:41
Advancements in Automated Insulin Delivery Systems

08:22
Exploring GLP-1 Receptor Agonists and Insulin Resistance

10:42
The Role of Exercise in Diabetes Management

14:07
Nutrition and Automated Insulin Delivery Systems

16:03
Quality of Life Improvements with AID Systems

17:55
Equity in Access to Diabetes Technology

19:18
Continuous Glucose Monitoring Innovations

24:05
Future Directions in Diabetes Management 

Show Notes & Resources

• Full Show Notes - Episode 9: ATTD 2025 
• 🎧 Download the Glucose Rap
• 📘 Insulin Resistance Guide
• 📊 CGM Accuracy Series
• 🎙️ Episode 8: Activity for Post-Meal Glucose Control
• 📎 Episode 6: Ten Tips to Optimise Time in Range with AID.